Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre
Clinical trials sponsored by Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre, explained in plain language.
-
Which ablation strategy works best for stubborn AFib?
Disease control OngoingThis study compares three catheter ablation techniques for people with persistent atrial fibrillation (AFib), a heart rhythm problem lasting 3 months to 3 years. About 617 adults having their first ablation will be randomly assigned to one of three strategies. The goal is to see …
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Experimental drug offers hope for children with devastating brain disorder
Disease control OngoingThis study gives one child with Cree leukoencephalopathy (CLE) access to an experimental drug called fosigotifator. CLE is a rare, inherited brain disease that destroys white matter and leads to early death. The drug targets the genetic cause of the disease and may slow or stop b…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Last hope: experimental drug given to single child with fatal brain disorder
Disease control OngoingThis study provides an experimental drug called fosigotifator to one patient with Cree Leukoencephalopathy, a rare and deadly brain disease that currently has no treatments. The goal is to see if the drug can slow or stop the brain damage and improve quality of life. The patient …
Phase: EARLY_PHASE1 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New Dual-Energy catheter aims to tame deadly heart rhythms
Disease control OngoingThis study tests a new catheter that uses a combination of pulsed field and radiofrequency energy to destroy the small areas of heart tissue causing ventricular tachycardia (a fast, dangerous heart rhythm). About 30 adults with recurrent VT will receive this ablation procedure. T…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
Can a diabetes drug protect kidneys in advanced disease?
Disease control OngoingThis study looks at whether canagliflozin, a drug used for diabetes, can safely reduce kidney damage in people with advanced chronic kidney disease (CKD), including those on dialysis. About 35 adults with stage 4 or 5 CKD will take the drug for up to 26 weeks. Researchers will me…
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New wireless sensor could improve jaundice treatment for newborns
Knowledge-focused OngoingThis study tests a new wireless sensor that continuously measures the amount of light therapy a newborn receives for jaundice. Currently, doctors check light levels only once a day with a handheld device, which may not be accurate. The goal is to see if the new sensor provides be…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Could wireless monitors replace wires in the NICU?
Knowledge-focused OngoingThis study is testing whether wireless sensors can safely and accurately monitor heart rate, breathing, temperature, and oxygen levels in 75 newborn babies in the NICU. The goal is to see if these sensors work as well as the standard wired monitors, and to gather feedback from do…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC
-
Listening for trouble: new sensor could spot breathing issues in preemies
Knowledge-focused OngoingThis study explores whether a new, non-invasive acoustic sensor can reliably detect breathing sounds and problems in premature infants. Researchers will monitor 50 preterm babies in the NICU, comparing the sensor's readings to standard airflow measurements. The goal is to see if …
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 05, 2026 11:56 UTC